MedTrace Logo

Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus

NCT00672074 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2017-04-14

No results posted yet for this study

Summary

The purpose of this study is to determine if ipamorelin is safe and effective in the management of post-operative ileus.

Conditions

  • Ileus

Interventions

DRUG

Ipamorelin

IV

DRUG

placebo

IV

Sponsors & Collaborators

  • Helsinn Therapeutics (U.S.), Inc

    lead INDUSTRY

Principal Investigators

  • Suzan Allen · Helsinn Therapeutics (U.S.), Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00672074 on ClinicalTrials.gov